Michael Grissinger's most recent trade in Aprea Therapeutics Inc was a trade of 4,185 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aprea Therapeutics Inc | Michael Grissinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 4,185 | 4,185 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Michael Grissinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 1,045 | 2,889 (0%) | 0% | 0 | Common Stock | |
| Adicet Bio Inc | Michael Grissinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 70,200 | 70,200 | - | - | Stock Option (Right to Buy) | |
| Akari Therapeutics Plc - ADR | Michael Grissinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 5,000,000 | 5,000,000 | - | - | Stock Option (Right to Buy) | |
| Aprea Therapeutics Inc | Michael Grissinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,185 | 4,185 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Michael Grissinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 1,045 | 1,844 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Michael Grissinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 2,000 | 2,000 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Michael Grissinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 500 | 799 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Michael Grissinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 29,575 | 29,575 | - | - | Stock Option (right to Buy) | |
| Aprea Therapeutics Inc | Michael Grissinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 5,995 | 5,995 (0%) | 0% | 0 | Common Stock |